257 filings
S-8
ETON
Eton Pharmaceuticals Inc
26 Mar 24
Registration of securities for employees
4:24pm
10-K/A
2023 FY
ETON
Eton Pharmaceuticals Inc
Annual report (amended)
22 Mar 24
4:17pm
8-K
ETON
Eton Pharmaceuticals Inc
22 Mar 24
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for Phenylketonuria
6:55am
10-K
2023 FY
ETON
Eton Pharmaceuticals Inc
Annual report
14 Mar 24
4:25pm
8-K
ETON
Eton Pharmaceuticals Inc
14 Mar 24
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
4:16pm
8-K
eo3xyb5 xi6nb2
21 Feb 24
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
6:55am
4
wttc f6bvnb6
15 Feb 24
Eton Pharmaceuticals / James R. Gruber ownership change
4:21pm
4
b8td00m0
15 Feb 24
Eton Pharmaceuticals / Jennifer McKie Adams ownership change
4:19pm
4
weics54
15 Feb 24
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:19pm
4
a7j7 m3n1knbf3
15 Feb 24
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
4:18pm
4
3j1643p u053xk3aj
15 Feb 24
Eton Pharmaceuticals / David Krempa ownership change
4:17pm
4
lb8j4ddt843
15 Feb 24
Eton Pharmaceuticals / PAUL V MAIER ownership change
4:16pm
4
079 8laanq
15 Feb 24
Eton Pharmaceuticals / NORBERT G RIEDEL ownership change
4:15pm
SC 13G/A
ollhy h6owjgq1h0qwlg
9 Feb 24
Eton Pharmaceuticals / Opaleye Management ownership change
4:05pm
8-K
qm4 gz3db
2 Feb 24
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
6:55am
8-K
7woegl8j
9 Nov 23
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
12:00am
8-K
e2mm0te
4 Oct 23
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
6:55am
8-K
qhgtttid xuj
10 Aug 23
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:15pm